Taiko Pharmaceutical Co.,Ltd.
Research Taiko Pharmaceutical Co.,Ltd. (4574.T) on Bullrun: market cap JPY 13.28B, P/E 18.9, dividend yield 1.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4574.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 13.28B
- P/E18.9
- Dividend yield1.3%
- Financial periodFY2025
- RevenueJPY 6.40B
- Revenue growth1.7%
- Net incomeJPY 923.00M
- Free cash flowJPY 510.00M
- Gross margin54.4%
Valuation Snapshot
latest market cap is JPY 13.28B; P/E is 18.9; dividend yield is 1.3%.
Peer valuation comparison
Latest P/E is 18.86x versus a Healthcare sector median of 21.8x (13.5% below).
Latest dividend yield is 1.25% versus a Healthcare sector median of 2.41% (48.1% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 6.40B | JPY 923.00M | JPY 510.00M | 54.4% | 18.38 | JPY 4.26B | JPY 970.00M | JPY 8.52B |
| FY2024 | JPY 6.29B | JPY 898.00M | JPY 175.00M | 58.3% | 17.9 | JPY 4.53B | JPY 2.21B | JPY 7.96B |
| FY2023 | JPY 6.12B | -JPY 3.61B | -JPY 421.00M | 42.1% | -76.25 | JPY 5.48B | JPY 3.25B | JPY 6.74B |
| FY2022 | JPY 5.04B | -JPY 4.90B | -JPY 2.08B | 21.4% | -112.26 | JPY 3.11B | JPY 3.81B | JPY 8.04B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 13.28B | 18.9 | 1.3% | 3.5 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 3.5 JPY, yield 1.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 3.3 JPY |
About Taiko Pharmaceutical Co.,Ltd.
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Taiko Pharmaceutical Co.,Ltd.'s market cap?
Taiko Pharmaceutical Co.,Ltd.'s market capitalization is JPY 13.28B.
What is Taiko Pharmaceutical Co.,Ltd.'s P/E ratio?
Taiko Pharmaceutical Co.,Ltd.'s price-to-earnings (P/E) ratio is 18.9.
Does Taiko Pharmaceutical Co.,Ltd. pay a dividend?
Taiko Pharmaceutical Co.,Ltd. has a dividend yield of 1.3%.
What does Taiko Pharmaceutical Co.,Ltd. do?
Taiko Pharmaceutical Co.,Ltd. manufactures and sells over-the-counter (OTC) medicines and quasi drugs in Japan and internationally. The company provides OTC medicines under the SEIROGAN, SEIROGAN TOI A and SEIROGAN Quick C, PISHUT OD Tablet brand names; and quasi-drugs under the RAPPA INTESTINAL REGULATOR BF brand names. It offers sanitation control products under the Cleverin PR, Cleverin Pro Stick, and Cleverin Pro name. In addition, the company manufactures and sells wood vinegar-based products. It exports its products.